1. Home
  2. RILY vs THRD Comparison

RILY vs THRD Comparison

Compare RILY & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RILY
  • THRD
  • Stock Information
  • Founded
  • RILY 1973
  • THRD 2019
  • Country
  • RILY United States
  • THRD United States
  • Employees
  • RILY N/A
  • THRD N/A
  • Industry
  • RILY Investment Managers
  • THRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • RILY Finance
  • THRD Health Care
  • Exchange
  • RILY Nasdaq
  • THRD Nasdaq
  • Market Cap
  • RILY 142.1M
  • THRD 157.4M
  • IPO Year
  • RILY 2007
  • THRD 2022
  • Fundamental
  • Price
  • RILY $3.16
  • THRD $5.16
  • Analyst Decision
  • RILY
  • THRD Hold
  • Analyst Count
  • RILY 0
  • THRD 3
  • Target Price
  • RILY N/A
  • THRD $5.00
  • AVG Volume (30 Days)
  • RILY 858.4K
  • THRD 1.1M
  • Earning Date
  • RILY 04-29-2025
  • THRD 05-14-2025
  • Dividend Yield
  • RILY 17.86%
  • THRD N/A
  • EPS Growth
  • RILY N/A
  • THRD N/A
  • EPS
  • RILY N/A
  • THRD N/A
  • Revenue
  • RILY $854,383,000.00
  • THRD N/A
  • Revenue This Year
  • RILY N/A
  • THRD N/A
  • Revenue Next Year
  • RILY N/A
  • THRD N/A
  • P/E Ratio
  • RILY N/A
  • THRD N/A
  • Revenue Growth
  • RILY N/A
  • THRD N/A
  • 52 Week Low
  • RILY $2.67
  • THRD $3.18
  • 52 Week High
  • RILY $40.09
  • THRD $16.94
  • Technical
  • Relative Strength Index (RSI)
  • RILY 39.62
  • THRD 80.42
  • Support Level
  • RILY $2.74
  • THRD $3.30
  • Resistance Level
  • RILY $3.44
  • THRD $5.15
  • Average True Range (ATR)
  • RILY 0.34
  • THRD 0.16
  • MACD
  • RILY -0.02
  • THRD 0.24
  • Stochastic Oscillator
  • RILY 37.69
  • THRD 99.47

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Share on Social Networks: